Endogenous Opioid Peptides Modulate the Effect of Corticotropin-Releasing Factor on Gonadotropin Release in the Primate*
- 1 September 1987
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 121 (3), 837-842
- https://doi.org/10.1210/endo-121-3-837
Abstract
Stress can induce endocrine abnormalities and menstrual dysfunction in the primate. Here, we examine the effects that CRF, the principal neurohormone in control of the hypothalamic-pituitary-adrenal axis, exerts on pulsatile gonadotropin secretion and the role that the endogenous opioid peptides may play in this phenomenon. Ovariectomized rhesus monkeys were given a 5-h continuous iv infusion of physiological saline (2 ml/h), human CRF (100 .mu.g/2 ml .cntdot. h), or hCRF plus the opiate receptor antagonist naloxone (2 mg/2ml/h; 5 mg in two experiments; n = 7 experiments/group). LH and FSH concentrations were measured at 15-min intervals for a 3-h preinfusion baseline control, during the 5-h infusion, and during a 2-h postinfusion observation period, while cortisol concentrations were measured at frequent intervals during the entire experiment. CRF infusion produced a progressive and significant decrease in both LH and FSH. Mean areas (.+-.SE) under the LH and FSH curves during the 5-h CRF infusion, expressed as a percentage of preinfusion baseline were 59.9 .+-. 4.6% and 83.0 .+-. 3.1% (.+-.SE), respectively (P < 0.001 and P < 0.01 vs. saline controls). Large amplitude LH pulses were abolished during the CRF infusion. However, after cessation of CRF infusion, there was a rapid resumption of LH pulsatile release in four of the seven experiments. Addition of naloxone to CRF prevented the CRF- mediated suppression of LH and FSH release. Mean areas for LH and FSH during the 5-h combined infusion were 100.3 .+-. 6.6% and 99.6 .+-. 4.3% of the preinfusion baseline, respectively (P < 0.001 and P < 0.05 vs. CRH alone; NS vs. saline), and pulsatile LH secretion was maintained. Regardless of whether naloxone was administered, CRF increased cortisol levels significantly. Mean cortisol levels at the end of the CRF and CRF plus naloxone infusions were 48.2 .+-. 10.4 and 52.9 .+-. 7.4 .mu.g/dl (.+-.SE), respectively, compared to 21.0 .+-. 3.0 with saline (P < 0.05). These results demonstrate that in the ovariectomized rhesus monkey, CRF suppresses the secretion of both LH and FSH, and this effect can be sustained. They also indicate that the CRF inhibitory action on gonadotropin is primarily mediated by endogenous opioid peptides, independent of glucocorticoid levels.This publication has 25 references indexed in Scilit:
- Hemorrhage-Induced Secretion of Corticotropin-Releasing Factor-Like Immunoreactivity into the Rat Hypophysial Portal Circulation and Its Inhibition by Glucocorticoids*Endocrinology, 1984
- The role of endogenous opioids in the blockade of reproductive function in the rat following exposure to acute stressPharmacology Biochemistry and Behavior, 1983
- Endogenous Opioid Regulation of Gonadotropin-Releasing Hormone Release from the Human Fetal Hypothalamusin Vitro*Journal of Clinical Endocrinology & Metabolism, 1983
- Synthetic corticotropin-releasing factor stimulates secretion of immunoreactive β-endorphin/β-lipotropin and ACTH by human fetal pituitaries in vitroLife Sciences, 1983
- Reversal of the anti-ovulatory action of stress in rats by prior administration of naloxone hydrochlorideReproduction, 1982
- Effects and Site of Action of Morphine on Gonadotropin Secretion in the Female Rhesus Monkey*Endocrinology, 1982
- Cerebrospinal fluid opioid activity in anorexia nervosaAmerican Journal of Psychiatry, 1982
- Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-EndorphinScience, 1981
- Endogenous Opiates Modulate Pulsatile Luteinizing Hormone Release in Humans*Journal of Clinical Endocrinology & Metabolism, 1981
- Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormoneLife Sciences, 1977